Waystar (WAY) Stock: Buy, Sell, or Hold?
WAY - Waystar Holding Corp. Common Stock
$23.47
0.41 (1.78%)
▲
5d:
-10.01%
30d:
-4.36%
90d:
+27.21%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Nov 04, 2026
Get Alerted When WAY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: WAY is down 10.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: WAY is down 10.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$39.01
Based on 8.3% avg growth
INTRINSIC VALUE TODAY
$24.22
3.1% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 14.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: WAY is currently trading at $23.47, which is considered oversold relative to its 30-day fair value range of $23.68 to $25.50. From a valuation perspective, the stock is trading at a discount (Forward PE: 12.5) compared to its historical average (14.0). Remarkably, the market is currently pricing in an annual earnings decline of 3.7% over the next few years. This pessimistic expectation contrasts with the company's recent 16.7% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, WAY is in a strong downtrend. The price is currently testing key support at $22.95. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: WAY scores 39/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $33.30 (+41.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, WAY is in a strong downtrend. The price is currently testing key support at $22.95. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: WAY scores 39/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $33.30 (+41.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$23.68 -
$25.50
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
Protect Your Profits
Holding WAY? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (39/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 41.9% below Wall St target ($33.30)
- WARNING: Composite score 45/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$23.68 -
$25.50
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$22.96
Resistance Level
$26.87
Current Trend
Strong Downtrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
12.50
Wall Street Target
$33.30
(+41.9%)
Revenue Growth (YoY)
18.1%
Earnings Growth (YoY)
16.7%
Profit Margin
11.2%
Valuation Discount vs History
-3.7% cheaper
PE vs Historical
12.5 vs 14.0
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-3.7%
(market-implied from PE analysis)
1-Year Target
$22.60
(-4%)
2-Year Target
$21.77
(-7%)
3-Year Target
$20.96
(-11%)
3-Yr Target (if PE normalizes)
(PE: 13→14)
$23.48
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.2, Growth: 12.5%)
$53.89
(+130%)
Base:
(SPY PE: 12.5, Growth: 12.5%)
$33.39
(+42%)
Bear:
(PE: 10.6, Growth: 12.5%)
$28.38
(+21%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (34x PE), but valuation improves significantly next year (13x PE) as earnings recover.
Trailing PE: 33.91 | Current EPS (TTM): $0.68
Bull Case
$50.73
(+116%)
Analyst growth 100.0%, PE expands to 37.3
Base Case
$46.12
(+97%)
Market implied 100.0%, PE stable at 33.9
Bear Case
$15.68
(-33%)
Severe decline -20.0%, PE contracts to 28.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 12.5 to 14.0
Stabilization Target:
$26.29
(+12.0%)
PE Expansion Potential:
+12.0%
Share & Embed Analysis
Last updated: September 12, 2026 11:29 AM ET
Data refreshes hourly during market hours. Next update: 12:29 PM
Data refreshes hourly during market hours. Next update: 12:29 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is WAY showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$294 | 39 SELL |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 42 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 49 HOLD |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 51 HOLD |
|
HQY
HealthEquity Inc |
STRONG BUY
14 analysts |
$119 | 47 HOLD |
Advanced WAY Option Strategies
Professional options setups generated by AI based on today's WAY price and gamma walls.
